Literature DB >> 25074767

Nongenetic risk factors for neovascular age-related macular degeneration.

Tina Ristau1, Lebriz Ersoy1, Moritz Hahn2, Anneke I den Hollander3, Bernd Kirchhof1, Sandra Liakopoulos1, Sascha Fauser1.   

Abstract

PURPOSE: To create a risk model for neovascular age-related macular degeneration (nAMD) based on nongenetic factors.
METHODS: In this case-control study, 1459 individuals were included, 445 patients showed nAMD and 1014 were healthy controls. Participants were randomly assigned into a training set (containing two-thirds of individuals) and a validation set. Stepwise logistic regression analysis was performed for 25 environmental risk factors in the training set. The risk model with the remaining factors was then validated in the validation set using receiver operating characteristics (ROC) curve and Hosmer-Lemeshow-Test. Additionally, a genetic risk model including variants in the complement factor H gene (CFH, rs1061170) and the age-related maculopathy susceptibility 2 gene (ARMS2, rs10490924) was generated.
RESULTS: The environmental risk model with the factors age, alcohol use, allergy, education, sunlight exposure, fish consumption, and physical exercise showed an AUC of 0.80 (95% confidence interval [CI] 0.76-0.84) in the training set. Validation of the model showed adequate calibration (Hosmer-Lemeshow P = 0.81). The AUC for the genetic model was 0.77 (95% CI 0.730-0.808), for the combined environmental and genetic model 0.92 (95% CI 0.887-0.947).
CONCLUSIONS: Seven nongenetic factors are able to provide equivalent discrimination between nAMD patients and controls to genetic risk models. Most of them are modifiable and give the opportunity for counseling patients. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  age-related macular degeneration; nongenetic risk factor

Mesh:

Substances:

Year:  2014        PMID: 25074767     DOI: 10.1167/iovs.14-14299

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Impact of allergy and atopy on the risk of pseudophakic cystoid macular edema.

Authors:  Friederike Schaub; Werner Adler; Meike C Koenig; Philip Enders; Rafael S Grajewski; Claus Cursiefen; Ludwig M Heindl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-24       Impact factor: 3.117

2.  Analysis of Genetic and Environmental Risk Factors and Their Interactions in Korean Patients with Age-Related Macular Degeneration.

Authors:  Se Joon Woo; Jeeyun Ahn; Margaux A Morrison; So Yeon Ahn; Jaebong Lee; Ki Woong Kim; Margaret M DeAngelis; Kyu Hyung Park
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

Review 3.  Neovascular Macular Degeneration: A Review of Etiology, Risk Factors, and Recent Advances in Research and Therapy.

Authors:  Arunbalaji Pugazhendhi; Margaret Hubbell; Pooja Jairam; Balamurali Ambati
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

4.  Genetic and environmental risk factors for reticular pseudodrusen in the EUGENDA study.

Authors:  Lebriz Altay; Sandra Liakopoulos; Aileen Berghold; Kerstin-Daniela Rosenberger; Angela Ernst; Anita de Breuk; Anneke I den Hollander; Sascha Fauser; Tina Schick
Journal:  Mol Vis       Date:  2021-12-31       Impact factor: 2.367

5.  Genetic and environmental risk factors for extramacular drusen.

Authors:  Lebriz Altay; Xavier Subiras; Laura Lorés de Motta; Tina Schick; Aileen Berghold; Carel B Hoyng; Anneke I den Hollander; Sascha Fauser; Srinivas R Sadda; Sandra Liakopoulos
Journal:  Mol Vis       Date:  2020-10-04       Impact factor: 2.367

6.  Voluntary Exercise Suppresses Choroidal Neovascularization in Mice.

Authors:  Ryan D Makin; Dionne Argyle; Shuichiro Hirahara; Yosuke Nagasaka; Mei Zhang; Zhen Yan; Nagaraj Kerur; Jayakrishna Ambati; Bradley D Gelfand
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-05-11       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.